{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:51:32Z","timestamp":1768834292277,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Perth Children's Hospital Foundation"},{"DOI":"10.13039\/501100001136","name":"Australian and New Zealand College of Anaesthetists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001136","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-2342-4","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T09:59:45Z","timestamp":1513936785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nitrous oxide (N2O) and subsequent open-label SSRI treatment of adolescents with depression (NOTAD): study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"18","author":[{"given":"Richard M.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice W. Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin C.","family":"Runions","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia K.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon R.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta S.","family":"von Ungern-Sternberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sommerfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian Daniel","family":"Zepf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,22]]},"reference":[{"key":"2342_CR1","volume-title":"National survey of mental health and wellbeing: summary of results","author":"Australian Bureau of Statistics","year":"2007","unstructured":"Australian Bureau of Statistics. National survey of mental health and wellbeing: summary of results. Canberra: Australian Bureau of Statistics; 2007."},{"key":"2342_CR2","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.neubiorev.2013.07.010","volume":"37","author":"T Outhred","year":"2013","unstructured":"Outhred T, Hawkshead BE, Wager TD, Das P, Malhi GS, Kemp AH. Acute neural effects of selective serotonin reuptake inhibitors versus noradrenaline reuptake inhibitors on emotion processing: implications for differential treatment efficacy. Neurosci Biobehav Rev. 2013;37:1786\u2013800.","journal-title":"Neurosci Biobehav Rev"},{"key":"2342_CR3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biopsych.2014.11.016","volume":"78","author":"P Nagele","year":"2015","unstructured":"Nagele P, Duma A, Kopec M, Gebara MA, Parsoei A, Walker M, Janski A, Panagopoulos VN, Cristancho P, Miller JP. Nitrous oxide for treatment-resistant major depression: a proof-of-concept trial. Biol Psychiatry. 2015;78:10\u20138.","journal-title":"Biol Psychiatry"},{"key":"2342_CR4","doi-asserted-by":"crossref","first-page":"9716","DOI":"10.1523\/JNEUROSCI.18-23-09716.1998","volume":"18","author":"S Mennerick","year":"1998","unstructured":"Mennerick S, Jevtovic-Todorovic V, Todorovic SM, Shen W, Olney JW, Zorumski CF. Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures. J Neurosci. 1998;18:9716\u201326.","journal-title":"J Neurosci"},{"key":"2342_CR5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nm0498-460","volume":"4","author":"V Jevtovi\u0107-Todorovi\u0107","year":"1998","unstructured":"Jevtovi\u0107-Todorovi\u0107 V, Todorov\u0107 S, Mennerick S, Powell S, Dikranian K, Benshoff N, Zorumski C, Olney J. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med. 1998;4:460\u20133.","journal-title":"Nat Med"},{"key":"2342_CR6","doi-asserted-by":"crossref","first-page":"8791","DOI":"10.1073\/pnas.0402825101","volume":"101","author":"P Nagele","year":"2004","unstructured":"Nagele P, Metz L, Crowder C. Nitrous oxide (N2O) requires the N-methyl-d-aspartate receptor for its action in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2004;101:8791\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2342_CR7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","volume":"63","author":"S Maeng","year":"2008","unstructured":"Maeng S, Zarate CA, Du J, Schloesser RJ, McCammon J, Chen G, Manji HK. Cellular mechanisms underlying the antidepressant effects of ketamine: role of \u03b1-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry. 2008;63:349\u201352.","journal-title":"Biol Psychiatry"},{"key":"2342_CR8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","volume":"475","author":"AE Autry","year":"2011","unstructured":"Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, Kavalali ET, Monteggia LM. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature. 2011;475:91\u20135.","journal-title":"Nature"},{"key":"2342_CR9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/1570159X12666140619204251","volume":"12","author":"G Serafini","year":"2014","unstructured":"Serafini G, Howland RH, Rovedi F, Girardi P, Amore M. The role of ketamine in treatment-resistant depression: a systematic review. Curr Neuropharmacol. 2014;12:444\u201361.","journal-title":"Curr Neuropharmacol"},{"key":"2342_CR10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","volume":"338","author":"RS Duman","year":"2012","unstructured":"Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science. 2012;338:68\u201372.","journal-title":"Science"},{"key":"2342_CR11","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 2010;329:959\u201364.","journal-title":"Science"},{"key":"2342_CR12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47:351\u20134.","journal-title":"Biol Psychiatry"},{"key":"2342_CR13","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63:856\u201364.","journal-title":"Arch Gen Psychiatry"},{"key":"2342_CR14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","volume":"71","author":"CA Zarate","year":"2012","unstructured":"Zarate CA, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A, Selter J, Marquardt CA, Liberty V, Luckenbaugh DA. Replication of ketamine\u2019s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry. 2012;71:939\u201346.","journal-title":"Biol Psychiatry"},{"key":"2342_CR15","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/bdi.12003","volume":"14","author":"DA Luckenbaugh","year":"2012","unstructured":"Luckenbaugh DA, Ibrahim L, Brutsche N, Franco\u2010Chaves J, Mathews D, Marquardt CA, Cassarly C, Zarate CA. Family history of alcohol dependence and antidepressant response to an N-methyl-d-aspartate antagonist in bipolar depression. Bipolar Disord. 2012;14:880\u20137.","journal-title":"Bipolar Disord"},{"key":"2342_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1567202612666150122122924","volume":"12","author":"GZ R\u00e9us","year":"2015","unstructured":"R\u00e9us GZ, Nacif MP, Abelaira HM, Tomaz DB, dos Santos MA, Carlessi AS, Matias BI, da Luz JR, Steckert AV, et al. Ketamine treatment partly reverses alterations in brain derived-neurotrophic factor, oxidative stress and energy metabolism parameters induced by an animal model of depression. Curr Neurovasc Res. 2015;12:73\u201384.","journal-title":"Curr Neurovasc Res"},{"key":"2342_CR17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/07853890.2015.1122216","volume":"48","author":"J Schaufler","year":"2016","unstructured":"Schaufler J, Ronovsky M, Savalli G, Cabatic M, Sartori S, Singewald N, Pollak D. Fluoxetine normalizes disrupted light-induced entrainment, fragmented ultradian rhythms and altered hippocampal clock gene expression in an animal model of high trait anxiety- and depression-related behavior. Ann Med. 2016;48:17\u201327.","journal-title":"Ann Med"},{"key":"2342_CR18","first-page":"191","volume-title":"Kiddie-SADS-Present and Lifetime version","author":"J Kaufman","year":"1996","unstructured":"Kaufman J, Birmaher B, Brent D, Rao U, Ryan N. Kiddie-SADS-Present and Lifetime version. Pittsburgh, PA: University of Pittsburgh; 1996. p. 191."},{"key":"2342_CR19","volume-title":"Wechsler Abbreviated Scale of Intelligence - Second Edition (WASI-II)","author":"D Wechsler","year":"2011","unstructured":"Wechsler D. Wechsler Abbreviated Scale of Intelligence - Second Edition (WASI-II). San Antonio, TX: Pearson Clinical; 2011."},{"key":"2342_CR20","first-page":"1","volume-title":"Depression in children and young people: identification and management, clinical guideline","author":"National Institute for Health and Care Excellence (NICE)","year":"2005","unstructured":"National Institute for Health and Care Excellence (NICE). Depression in children and young people: identification and management, clinical guideline. London: NICE; 2005. p. 1\u201359."},{"key":"2342_CR21","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archpsyc.64.10.1132","volume":"64","author":"JS March","year":"2007","unstructured":"March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B. The Treatment for Adolescents with Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007;64:1132\u201343.","journal-title":"Arch Gen Psychiatry"},{"key":"2342_CR22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/j.1440-1614.2000.00729.x","volume":"34","author":"M Sawyer","year":"2000","unstructured":"Sawyer M, Kosky R, Graetz B, Arney F, Zubrick S, Baghurst P. The National Survey of Mental Health and Wellbeing: the child and adolescent component. Aust N Z J Psychiatry. 2000;34:214\u201320.","journal-title":"Aust N Z J Psychiatry"},{"key":"2342_CR23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(09)60329-9","volume":"374","author":"I Chalmers","year":"2009","unstructured":"Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374:86\u20139.","journal-title":"Lancet"},{"key":"2342_CR24","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/bmj.39590.732037.47","volume":"336","author":"P Glasziou","year":"2008","unstructured":"Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews? Br Med J. 2008;336:1472\u20134.","journal-title":"Br Med J"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2342-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T10:37:47Z","timestamp":1570531067000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-2342-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2342"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-2342-4","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"617"}}